HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

3'-deamino-3'-hydroxydoxorubicin

substitution of the basic amino group at the C-3' of doxorubicin by a hydroxyl group overcomes recognition of the multidrug resistant P-glycoprotein and limits cardiotoxicity; structure given in first source
Also Known As:
3'-deamino-4'-epi-3'-hydroxydoxorubin; 3-DHD; hydroxyrubicin; 5,12-Naphthacenedione, 10-((2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-
Networked: 3 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Ali, Kashif: 1 article (06/2018)
2. Ansari, Saqib Hussain: 1 article (06/2018)
3. Baig, Mirza Tasawer: 1 article (06/2018)
4. Baig, Nida: 1 article (06/2018)
5. Shamsi, Tahir Sultan: 1 article (06/2018)
6. Sial, Ali Akbar: 1 article (06/2018)

Related Diseases

1. Cardiotoxicity
2. Leukemia P388
3. Febrile Neutropenia
4. Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)

Related Drugs and Biologics

1. Doxorubicin (Adriamycin)
2. Member 1 Subfamily B ATP Binding Cassette Transporter
3. Hydroxyl Radical
4. Vincristine (Oncovin)
5. Prednisolone (Predate)
6. Cyclophosphamide (Cytoxan)
7. Rituximab (Mabthera)
8. R-CHOP protocol